ANTIFUNGAL SUSCEPTIBILITIES OF ASPERGILLUS SPP. STRAINS ISOLATED FROM INVASIVE ASPERGILLOSIS CASES

被引:0
|
作者
Gurcan, Saban [1 ]
Tikvesli, Melek [1 ]
Eryildiz, Canan [1 ]
Evci, Canan [2 ]
Ener, Beyza [2 ]
机构
[1] Trakya Univ, Tip Fak, Tibbi Mikrobiyol Anabilim Dali, Edirne, Turkey
[2] Uludag Univ, Tip Fak, Tibbi Mikrobiyol Anabilim Dali, Busa, Turkey
来源
MIKROBIYOLOJI BULTENI | 2010年 / 44卷 / 02期
关键词
Aspergillosis; Aspergillus spp; antifungal susceptibility; microdilution; FUNGAL-INFECTIONS; ITRACONAZOLE;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aspergillus species found abundantly in the outer environment and hospital setting may lead to serious morbidity and mortality particularly in patients with suppressed immunity This retrospective study was aimed to investigate the antifungal susceptibilities of Aspergillus spp isolated from aspergillosis cases being hospitalized Aspergillus spp. isolated from samples of the patients with suspected fungal infections between January of 2002 and October of 2007, were investigated A total of 678 samples (420 lower respiratory tract, 202 sterile body fluids, and 56 biopsy/tissue specimens) from 569 patients were included in the study. The samples were incubated in 25 degrees C and 35 degrees C on brain-heart-infusion agar supplemented with blood and on Sabouraud dextrose agar Gram and Giemsa stained samples were also examined by microscopy Mold type of fungi were identified by conventional techniques "Invasive aspergillosis" was described according to criteria of Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer. A.fumigatus (n= 8), A.flavus (n= 2) and A niger (n= 2) were isolated from 12 patients' samples (2.1%), 9 of them were lower respiratory tract and one of each was ascid, brain biopsy and pleural fluid specimens. All of those patients have had an underlying diseases such as malignancy The susceptibility of the isolates to caspofungin, voriconazole, itraconazole and amphotericin B was tested by broth microdilution susceptibility testing and to posaconazole by E-test (AB Biodisk, Sweden). The lowest minimum inhibitory concentration (MIC) (<= 0.125 mu g/ml) values were detected for caspofungin and posaconazole for Aspergillus spp, however, the highest MIC values were detected for amphotericin B (> 1 mu g/ml) MIC values of the all strains except one, were detected as <= 0 5 mu g/ml for voriconazole and itraconazole In one A niger strain itraconazole MIC value was 2 mu g/ml Since the number of other species was low, MIC(50) value was determined only for A fumigatus strains and it was found that the highest MIC(50) value was for amphotericin B (2 mu g/ml) and the lowest MIC(50) values were for posaconazole (0.064 mu g/ml), caspofungin (0 064 mu g/ml), itraconazol (0 25 mu g/ml) and voriconazol (0.25 mu g/ml). Since caspofungin and posaconazole revealed the lowest MIC values, they should be taken into consideration in choice of therapy of aspergillosis cases in our hospital.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [1] Detection of Virulence Factors and Antifungal Susceptibilities of Fusarium Strains Isolated from Keratitis Cases
    Cuhadar, Tugba
    Karabicak, Nilgun
    Ozdil, Tugba
    Ozgur, Didem
    Otag, Feza
    Hizel, Kenan
    Kalkanci, Ayse
    MIKROBIYOLOJI BULTENI, 2018, 52 (03): : 247 - 258
  • [2] Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species
    Rozaliyani, Anna
    Abdullah, Asriyani
    Setianingrum, Findra
    Sjamsuridzal, Wellyzar
    Wahyuningsih, Retno
    Bowolaksono, Anom
    Fatril, Ayu Eka
    Adawiyah, Robiatul
    Tugiran, Mulyati
    Syam, Ridhawati
    Wibowo, Heri
    Kosmidis, Chris
    Denning, David W.
    JOURNAL OF FUNGI, 2022, 8 (04)
  • [3] Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.
    Stemler, Jannik
    Toebben, Christina
    Lass-Floerl, Cornelia
    Steinmann, Joerg
    Ackermann, Katharina
    Rath, Peter-Michael
    Simon, Michaela
    Cornely, Oliver Andreas
    Koehler, Philipp
    JOURNAL OF FUNGI, 2023, 9 (04)
  • [4] The antifungal susceptibilities of oral Candida spp. isolates from HIV-infected patients
    Satana, Dilek
    Genc, Gonca Erkose
    Erturan, Zayre
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2010, 4 (17): : 1831 - 1835
  • [5] Antifungal Therapies for Aspergillus spp.: Present and Future
    Eschenauer, Gregory A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (01) : 61 - 68
  • [6] Triazole-resistant Aspergillus luchuensis, an industrially important black Aspergillus spp. used in fermentation in East Asia, isolated from the patient with invasive pulmonary aspergillosis in China
    Wang, Qiqi
    Li, Yun
    Li, Yanming
    Osherov, Nir
    Goldman, Gustavo H.
    Verweij, Paul E.
    Zheng, Bo
    Li, Ruoyu
    Chen, Wei
    Liang, Tianyu
    Wan, Zhe
    Liu, Wei
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 1435 - 1438
  • [7] Prevalence of chronic pulmonary aspergillosis and the antifungal drug resistance of Aspergillus spp. in pulmonary tuberculosis patients in Uzbekistan
    Toychiev, Abdurakhim
    Belotserkovets, Vera
    Ignat'ev, Nikolay
    Madrakhimov, Shavkat
    Shaislamova, Mukambar
    Osipova, Svetlana
    TROPICAL DOCTOR, 2022, 52 (04) : 515 - 521
  • [8] In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole
    Kaya, Ayse Demet
    Kiraz, Nuri
    MYCOSES, 2007, 50 (06) : 447 - 450
  • [9] Molecular Identification and Antifungal Susceptibilities of Black Aspergillus Isolates from Otomycosis Cases in Hungary
    Szigeti, Gyoengyi
    Kocsube, Sandor
    Doczi, Ilona
    Bereczki, Laszlo
    Vagvoelgyi, Csaba
    Varga, Janos
    MYCOPATHOLOGIA, 2012, 174 (02) : 143 - 147
  • [10] Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp.
    Jose Caston, Juan
    Jose Linares, Maria
    Rivero, Antonio
    Casal, Manuel
    Torre-Cisneros, Julian
    MEDICINA CLINICA, 2012, 139 (15): : 668 - 671